PD-L1 Testing in Patients with Breast Cancer: Controversies and Current Practice
Sign Up to like & getrecommendations! Published in 2019 at "Current Breast Cancer Reports"
DOI: 10.1007/s12609-019-00340-4
Abstract: Atezolizumab has emerged as a novel treatment in patients with triple-negative breast cancer showing unprecedented survival gain. This breakthrough benefit is exclusively observed in PD-L1-positive patients, but PD-L1 positivity still lacks a reliable definition. In… read more here.
Keywords: testing patients; patients breast; breast cancer; practice ... See more keywords
Annexin A1 influences in breast cancer: Controversies on contributions to tumour, host and immunoediting processes.
Sign Up to like & getrecommendations! Published in 2017 at "Pharmacological research"
DOI: 10.1016/j.phrs.2017.02.011
Abstract: Annexin A1 is a multifunctional protein characterised by its actions in modulating the innate and adaptive immune response. Accumulating evidence of altered annexin A1 expression in many human tumours raises interest in its functional role… read more here.
Keywords: influences breast; annexin influences; breast cancer; host ... See more keywords